Cordarone/Amiodarone MDL To Be Considered May 26

(April 20, 2016, 8:47 AM EDT) -- WASHINGTON, D.C. — The Judicial Panel on Multidistrict Litigation on May 26 will hear arguments on the centralization of nine Cordarone/amiodarone lawsuits (In Re: Cordarone (Amiodarone) Marketing, Sales Practices and Products Liability Litigation, MDL Docket No. 2706, JMPDL).

On March 3, Heather Moore Cook asked the panel to centralize lawsuits that involve Wyeth Pharmaceuticals Inc. and parent company Pfizer Inc., Par Pharmaceutical Cos. Inc., Novartis Pharmaceuticals Corp. and subsidiaries Sandoz Inc. and Eon Labs Inc., Teva Pharmaceuticals USA Inc. and subsidiary Barr Laboratories Inc., Upsher-Smith Laboratories...
To view the full article, register now.